These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 35921119

  • 1. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, Pomfret EA.
    JAMA Surg; 2022 Oct 01; 157(10):926-932. PubMed ID: 35921119
    [Abstract] [Full Text] [Related]

  • 2. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 01; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 3. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH, Kim DG, Kang M, Koh HH, Choi MC, Min EK, Lee JG, Kim MS, Joo DJ.
    Int J Surg; 2023 Nov 01; 109(11):3459-3466. PubMed ID: 37565633
    [Abstract] [Full Text] [Related]

  • 4. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 01; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 5. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov 01; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 6. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C, Liu H, Zhang X, Ganoza A, Crane A, Powers C, Gunabushanam V, Behari J, Molinari M.
    BJS Open; 2024 May 08; 8(3):. PubMed ID: 38837956
    [Abstract] [Full Text] [Related]

  • 7. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS, Ruebner RL, Abt PL.
    Am J Transplant; 2015 Oct 08; 15(10):2732-8. PubMed ID: 25969133
    [Abstract] [Full Text] [Related]

  • 8. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS, Kaplan B, Jackson WE, Saben JL, Schold JD, Pomfret EA, Pomposelli JJ.
    Int J Surg; 2023 Sep 01; 109(9):2714-2720. PubMed ID: 37226874
    [Abstract] [Full Text] [Related]

  • 9. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC, Fung JY, Pang HH, Leung CK, Li HF, Sin SL, Ma KW, She BW, Dai JW, Chan AC, Cheung TT, Lo CM.
    Hepatology; 2021 Jun 01; 73(6):2441-2454. PubMed ID: 33006772
    [Abstract] [Full Text] [Related]

  • 10. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 01; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 11. Sex Disparity in Liver Transplant and Access to Living Donation.
    Karnam RS, Chen S, Xu W, Chen C, Elangainesan P, Ghanekar A, McGilvray I, Reichman T, Sayed B, Selzner M, Sapisochin G, Galvin Z, Hirschfield G, Asrani SK, Selzner N, Cattral M, Lilly L, Bhat M.
    JAMA Surg; 2021 Nov 01; 156(11):1010-1017. PubMed ID: 34406347
    [Abstract] [Full Text] [Related]

  • 12. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S.
    Liver Transpl; 2021 Jul 01; 27(7):971-983. PubMed ID: 33492764
    [Abstract] [Full Text] [Related]

  • 13. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan 01; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A, Patel MS, VanWagner LB, Lee WM, Asrani SK, Mufti AR, Rich NE, Vagefi PA, Shah JA, Kerr TA, Pedersen M, Hanish S, Singal AG, Cotter TG.
    Liver Transpl; 2024 Jan 01; 30(1):72-82. PubMed ID: 37490432
    [Abstract] [Full Text] [Related]

  • 16. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
    Beal EW, Akateh C, Tumin D, Bagante F, Black SM, Washburn K, Azouley D, Pawlik TM.
    Exp Clin Transplant; 2020 Aug 01; 18(4):491-497. PubMed ID: 31050611
    [Abstract] [Full Text] [Related]

  • 17. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson GE, Foley D, Mezrich JD, Kanmaz T, Andaçoğlu OM, D'Alessandro AM, Acarlı KS, Kalayoğlu M, Fernandez LA.
    Turk J Med Sci; 2021 Apr 30; 51(2):610-622. PubMed ID: 33037873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T.
    Transplantation; 2024 Mar 01; 108(3):713-723. PubMed ID: 37635282
    [Abstract] [Full Text] [Related]

  • 20. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM.
    Hepatology; 2012 Jan 01; 55(1):192-8. PubMed ID: 21898487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.